可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Richards AM, Troughton R, Lainchbury J, et al. Guiding and monitoring of heart failure therapy with NTProBNP: concepts and clinical studies [J]. J Card Fail,2005,11(5 Suppl):S34-S37.
[2]孙静,钱安斌. 小剂量倍他乐克治疗充血性心力衰竭对血浆BNP水平的影响[J]. 心脏杂志,2005,17(2):140-141.
[3]宋浩明,罗明,邓南伟. 扩张型心肌病与心绞痛患者心肌营养素1与脑钠肽的变化[J]. 心脏杂志,2002,14(2):132-133
[4]Cowie MR ,Mendez GF. BNP and congestive heart failure[J]. Prog Cardiovasc Dis,2002,44(4):293-321.
[5]Nakagawa K,Yamaguchi T. Plasma concentrations of atrial and brain natriuretic peptides in a case with hypertensive encephalopathy[J]. Neurol Res, 2002, 24(6):627-630.
[6]Suzuki M,Yamamoto K,Watanabe S,et al. Association between elevated brain natriuretic peptidelevels and development of left ventricular hypertrophy in patients with hypertension[J]. Am J Med,2000,108(8):627-633.
[7]Karagiannis A, Tziomalos K, Zamboulis C. Plasma Btype natriuretic peptide is related to left ventricular mass in hypertensive patients[J]. Eur Heart J,2004,25(21):1967.
[8]Kohno M, Minami M,Kano H,et al. Effect of angiotensin converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left ventricular hypertrophy[J]. Metabolism, 2000, 49 (10):1356-1360.